Venture Investors See China Remaining Attractive Despite High Valuations

Shanghai is ready to go full speed ahead to become a global pharma hub.
Shanghai retains its lure for biotech investors seeking exits through IPOs • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from China

More from Focus On Asia